Data & analytics
Who travels for stem cell therapy — and why
An illustrative view of source-market interest. This index is not a patient-volume estimate and should not be used as evidence of treatment demand or outcomes.
Relative demand index by source market
Why they travel
- USA — compare the exact product, indication, regulatory status and total journey cost.
- UK — limited availability and long private waits.
- Gulf — high willingness to pay, family-led care, fast medical visas.
- Germany — same EU quality at home costs €15–35k; Bulgaria is the price-shock alternative.
Relative index (illustrative), based on 2025–26 medical-tourism reporting.